diadenosine 5',5''''-p1,p6-hexaphosphate has been researched along with 1,3-dipropyl-8-cyclopentylxanthine in 1 studies
| Studies (diadenosine 5',5''''-p1,p6-hexaphosphate) | Trials (diadenosine 5',5''''-p1,p6-hexaphosphate) | Recent Studies (post-2010) (diadenosine 5',5''''-p1,p6-hexaphosphate) | Studies (1,3-dipropyl-8-cyclopentylxanthine) | Trials (1,3-dipropyl-8-cyclopentylxanthine) | Recent Studies (post-2010) (1,3-dipropyl-8-cyclopentylxanthine) |
|---|---|---|---|---|---|
| 52 | 0 | 5 | 1,301 | 1 | 165 |
| Protein | Taxonomy | diadenosine 5',5''''-p1,p6-hexaphosphate (IC50) | 1,3-dipropyl-8-cyclopentylxanthine (IC50) |
|---|---|---|---|
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 0.0051 | |
| Adenosine receptor A3 | Rattus norvegicus (Norway rat) | 0.0038 | |
| Adenosine receptor A2a | Homo sapiens (human) | 0.2033 | |
| Adenosine receptor A2b | Homo sapiens (human) | 0.0234 | |
| Adenosine receptor A1 | Homo sapiens (human) | 0.0083 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Assmann, G; Löwe, S; Nofer, JR; Schlüter, H; Tepel, M; Zidek, W | 1 |
1 other study(ies) available for diadenosine 5',5''''-p1,p6-hexaphosphate and 1,3-dipropyl-8-cyclopentylxanthine
| Article | Year |
|---|---|
Diadenosine polyphosphates regulate cytosolic calcium in human fibroblast cells by interaction with P2x purinoceptors coupled to phospholipase C.
Topics: Bridged-Ring Compounds; Calcium; Calcium Channel Blockers; Cells, Cultured; Cytosol; Dinucleoside Phosphates; Fibroblasts; Fura-2; Humans; Manganese; Nickel; Norbornanes; Phosphodiesterase Inhibitors; Purinergic Antagonists; Receptors, Purinergic; Suramin; Theobromine; Thiocarbamates; Thiones; Type C Phospholipases; Vasoconstrictor Agents; Verapamil; Xanthines | 1996 |